ESTRO 2025 - Abstract Book

S2331

Interdisciplinary – Health economics & health services research

ESTRO 2025

treatment, as capital vs. operational costs or based on resources used at each treatment step. Overhead costs were inconsistently addressed: as part of indirect costs, included in operational costs or categorized separately. Output measures included i.e. costs per fraction, patient, activity or capital expenditure. Studies’ quality was robust, with 100%, 92% and 88% adherence to the introduction, measurement of resources and cost valuation, and study parameters items, respectively.